Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Burchell

Showing results (241-250 of 264) with videos related to

Pageof 27
Sort By:
A Listing of Research in the Cardiovascular Field|February 19, 2014
PULMONARY VASCULAR DISEASE AND COR PULMONALEH B BURCHELL, A COURNAND, R EBERT, et al.
Cardiovascular Research|March 1, 1976
Effect of nitroglycerin with and without systemic hypotension on canine regional myocardial tritiated water depositionN F Paradise, M R Tripp, H B Burchell, et al.
Pharmacogenetics|February 24, 2001
Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bankM B Fisher, M Vandenbranden, K Findlay, et al.
Biochemical Pharmacology|May 5, 1993
Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferasesK W Bock, A Forster, H Gschaidmeier, et al.
Archives of Biochemistry and Biophysics|October 6, 1997
A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1M P Pritchard, R Ossetian, D N Li, et al.
Cancer Research|January 15, 1997
Preclinical prediction of factors influencing the elimination of 5,6-dimethylxanthenone-4-acetic acid, a new anticancer drugJ O Miners, L Valente, K J Lillywhite, et al.
Pharmacogenetics|March 25, 1998
Functional co-expression of CYP2D6 and human NADPH-cytochrome P450 reductase in Escherichia coliM P Pritchard, M J Glancey, J A Blake, et al.
Molecular Pharmacology|March 1, 1997
Arginine 52 and histidine 54 located in a conserved amino-terminal hydrophobic region (LX2-R52-G-H54-X3-V-L) are important amino acids for the functional and structural integrity of the human liver UDP-glucuronosyltransferase UGT1*6C Senay, M Ouzzine, E Battaglia, et al.
Biochemical Society Transactions|August 1, 1987
The molecular biology of UDP-glucuronyltransferasesB Burchell, M R Jackson, R B Coarser, et al.
Archives of Biochemistry and Biophysics|October 1, 1995
Cloning and expression of a rat liver phenobarbital-inducible UDP-glucuronosyltransferase (2B12) with specificity for monoterpenoid alcoholsM D Green, D J Clarke, E M Oturu, et al.
Pageof 27

Showing results (241-250 of 264) with videos related to

Sort By:
Pageof 27
A Listing of Research in the Cardiovascular Field|February 19, 2014
PULMONARY VASCULAR DISEASE AND COR PULMONALEH B BURCHELL, A COURNAND, R EBERT, et al.
Cardiovascular Research|March 1, 1976
Effect of nitroglycerin with and without systemic hypotension on canine regional myocardial tritiated water depositionN F Paradise, M R Tripp, H B Burchell, et al.
Pharmacogenetics|February 24, 2001
Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bankM B Fisher, M Vandenbranden, K Findlay, et al.
Biochemical Pharmacology|May 5, 1993
Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferasesK W Bock, A Forster, H Gschaidmeier, et al.
Archives of Biochemistry and Biophysics|October 6, 1997
A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1M P Pritchard, R Ossetian, D N Li, et al.
Cancer Research|January 15, 1997
Preclinical prediction of factors influencing the elimination of 5,6-dimethylxanthenone-4-acetic acid, a new anticancer drugJ O Miners, L Valente, K J Lillywhite, et al.
Pharmacogenetics|March 25, 1998
Functional co-expression of CYP2D6 and human NADPH-cytochrome P450 reductase in Escherichia coliM P Pritchard, M J Glancey, J A Blake, et al.
Molecular Pharmacology|March 1, 1997
Arginine 52 and histidine 54 located in a conserved amino-terminal hydrophobic region (LX2-R52-G-H54-X3-V-L) are important amino acids for the functional and structural integrity of the human liver UDP-glucuronosyltransferase UGT1*6C Senay, M Ouzzine, E Battaglia, et al.
Biochemical Society Transactions|August 1, 1987
The molecular biology of UDP-glucuronyltransferasesB Burchell, M R Jackson, R B Coarser, et al.
Archives of Biochemistry and Biophysics|October 1, 1995
Cloning and expression of a rat liver phenobarbital-inducible UDP-glucuronosyltransferase (2B12) with specificity for monoterpenoid alcoholsM D Green, D J Clarke, E M Oturu, et al.
Pageof 27